-
Product Insights
Eastern Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Eastern Equine Encephalitis Pipeline Drugs Market Report Overview The Eastern Equine Encephalitis pipeline drugs market research report provides comprehensive information on the Eastern Equine Encephalitis targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Eastern Equine Encephalitis targeted therapeutics development with respective active and dormant or discontinued projects.
-
Product Insights
Western Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Western Equine Encephalitis Drugs Development Market Report Overview Western equine encephalitis is a disease that is spread to humans by infected mosquitoes. Western equine encephalitis is caused by the western equine encephalitis virus, an arbovirus. Symptoms range from mild to severe and may include only fever and headache to encephalitis with delirium, disorientation, or coma. The western equine encephalitis pipeline drugs market research report provides comprehensive information on the therapeutics under development for western equine encephalitis, complete with analysis by...
-
Product Insights
Influenzavirus B Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Influenzavirus B Infections Clinical Trials Market Report Overview The influenzavirus B infections clinical trial market research report provides an overview of the influenzavirus B infections clinical trials scenario. The report provides top-line data relating to the clinical trials on influenzavirus B infections. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points...
-
Sector Analysis
Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Report Overview Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. Â Influenza infection is normally self-limiting. Symptoms generally last for one to two weeks, but most people infected with influenza do not need or seek medical treatment. The Seasonal Influenza Therapeutics (SIT) marketed and pipeline drugs market research report provides a data-driven overview...
-
Product Insights
Pertussis (Whooping Cough) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pertussis, also known as whooping cough, is a highly contagious respiratory disease. It is caused by the bacterium Bordetella pertussis. Symptoms include runny nose, nasal congestion, sneezing, red, watery eyes, and dry cough. Treatment includes antibiotics. The Pertussis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Pertussis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological...
-
Sector Analysis
Seasonal Influenza Vaccines – US Drug Forecast and Market Analysis to 2025
Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk patient populations such as the elderly and young children, make prompt and effective treatment with antiviral medication very difficult. For these reasons, prophylactic vaccination is the preferred intervention for seasonal influenza. The US will experience solid growth in...
-
Sector Analysis
Seasonal Influenza Vaccines – Japan Drug Forecast and Market Analysis to 2025
Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk patient populations such as the elderly and young children, make prompt and effective treatment with antiviral medication very difficult. For these reasons, prophylactic vaccination is the preferred intervention for seasonal influenza. The projected drivers for growth of the...
-
Sector Analysis
Seasonal Influenza Vaccines – 5EU Drug Forecast and Market Analysis to 2025
Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk patient populations such as the elderly and young children, make prompt and effective treatment with antiviral medication very difficult. For these reasons, prophylactic vaccination is the preferred intervention for seasonal influenza. A quadrivalent formulation of Intanza Intradermal is...
-
Sector Analysis
EpiCast Report: Seasonal Influenza – Epidemiology Forecast to 2025
Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses resulting in mild to severe influenza-like illness. Seasonal influenza affects persons of all ages. Each year, between 5% and 15% of the world's population is affected by seasonal influenza (WHO, 2013). Complications of influenza include pneumonia, bronchitis, ear infections, sinus infections, and worsening of chronic medical conditions such as congestive heart failure, asthma, or diabetes. Vaccination has been shown to reduce influenza morbidity and mortality...
-
Sector Analysis
EpiCast Report: Hepatitis C Virus – Epidemiology Forecast to 2025
Hepatitis C is a blood-borne liver disease caused by the hepatitis C virus (HCV). HCV can cause both acute and chronic hepatitis infection. According to the World Health Organization (WHO), an estimated 130–150 million individuals worldwide are affected with chronic HCV and about 500,000 people died of HCV-related conditions, including liver cirrhosis and hepatocellular carcinoma (HCC), in 2010 (Lozano et al., 2012; WHO, 2015). In the 9MM, GlobalData epidemiologists forecast that the anti-HCV+ total prevalent cases will increase from 19,842,780...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.